NEET-PG 2015 Practice Questions

Q: Which of the following does not predispose to leukemia?

Alcohol. ***Alcohol*** - Alcohol consumption does not have a well-established association with an increased risk of leukemia compared to other factors. - While excessive alcohol can impact overall health, it is not considered a primary risk factor for developing leukemia. *Chemical exposure* - Certain chemicals, such as **benzene** and **formaldehyde**, are known to be **leukemogenic** and can increase the risk of leukemia. [1] - Occupational exposure to these chemicals has been linked to **acute myeloid leukemia (AML)** and other types of leukemia. [1] *Smoking* - Smoking has been clearly associated with an increased risk of **acute myeloid leukemia (AML)** and other hematologic malignancies. [1] - The toxins in tobacco smoke can cause **DNA damage**, contributing to the development of leukemia. *Genetic disorder* - Certain genetic disorders, like **Down syndrome** and **Fanconi anemia**, are associated with an increased risk of leukemia. - Individuals with these genetic predispositions have a higher likelihood of developing various forms of leukemia.

Q: Which subtype of Acute Myeloid Leukemia (AML) is associated with the best prognosis?

Acute promyeloblastic leukemia (M3). ***Acute promyeloblastic leukemia (M.3)*** [1] - **Best prognosis** in acute myeloid leukemia (AML) is associated with acute promyeloblastic leukemia due to its responsiveness to **all-trans retinoic acid (ATRA)** treatment. [1] - This type often presents with a **prominent coagulopathy**, but successful treatment can lead to **long-term remission**. *Acute monocytic leukemia* - Generally associated with **poor prognosis** and is characterized by a high white blood cell count and organ infiltration. - It lacks the favorable features seen in acute promyeloblastic leukemia, such as effective treatment outcomes. *Erythroleukemia* - Known for having a **poor prognosis** due to its aggressive nature and frequent association with complex chromosomal abnormalities. [1] - Treatment responses are often suboptimal compared to that of acute promyeloblastic leukemia. *Acute myelomonocytic leukemia* - Typically has an **intermediate prognosis** [1] and presents with a mixture of myeloid and monocytic features. - It does not have the same treatment responsiveness and favorable outcomes as seen in acute promyeloblastic leukemia.

Q: Which antigen is tested in routine Rh typing?

D antigen. ***D antigen*** - Routine Rh typing specifically tests for the **D antigen**, which determines the Rh status of an individual as Rh-positive or Rh-negative [1]. - The presence of the **D antigen** is crucial for blood transfusions and pregnancy management [1]. *A antigen* - The **A antigen** is tested in the context of the ABO blood group system, not specifically for Rh typing. - It does not provide information regarding the Rh factor which is critical in blood compatibility. *C antigen* - Similar to the **A antigen**, the **C antigen** is part of the broader Rh system but is not routinely assessed in standard Rh typing. - Its testing is typically reserved for specific clinical scenarios involving Rh incompatibility. *B antigen* - The **B antigen** pertains to the ABO blood group and does not relate to the Rh factor or routine Rh typing. - Rh typing is solely focused on the **presence of the D antigen** to determine the Rh status. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 627-628.

Q: Which of the following is NOT seen in polycythemia vera?

Increased erythropoietin. ***Increased erythropoietin*** - In polycythemia vera, patients usually exhibit **low erythropoietin levels** due to feedback inhibition from increased red blood cell mass. - The condition is driven by a **myeloproliferative disorder** [2], not by increased erythropoietin stimulation. *Most common cause of polycythemia* - This option is incorrect because polycythemia vera is specifically a type of **primary polycythemia** [1], rather than the most common cause, which is often **secondary causes** such as hypoxia or abnormal erythropoietin production. - Other causes including chronic lung disease or renal tumors are more prevalent sources of increased red blood cell production. *Intrinsic abnormality of hematopoietic precursors* - While polycythemia vera indeed involves an **abnormality in hematopoietic stem cells** [1], it is not the only mechanism leading to polycythemia; many cases have secondary causes. - Hence, this option misrepresents the specific and more accurate characterization of polycythemia vera. *Erythropoietin independent growth of red cell progenitors* - Polycythemia vera is associated with **erythropoietin-independent** proliferation of hematopoietic cells [2], which is characteristic of the condition due to mutations in **JAK2** [2,3]. - This accurately reflects a significant feature of the disease, aligning closely with the pathophysiology. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 663-664. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 614-615. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 626-627.

Q: Radiotherapy induced radiation pneumonitis is mediated by all of the following cytokines and factors except -

PAF. ***PAF*** - **Platelet-activating factor (PAF)** is primarily involved in **anaphylaxis**, **asthma**, and **allergic responses**, mediating inflammation through platelet aggregation and smooth muscle contraction. - While it has pro-inflammatory effects, it is **not a primary mediator** of the specific inflammatory cascade seen in radiotherapy-induced radiation pneumonitis. *TNF-α* - **Tumor Necrosis Factor-alpha (TNF-α)** is a crucial **pro-inflammatory cytokine** that plays a significant role in the initial acute phase of radiation pneumonitis. - It induces **cytotoxicity**, **apoptosis**, and the production of other inflammatory mediators, contributing to lung tissue damage. *TGF-β* - **Transforming Growth Factor-beta (TGF-β)** is a key cytokine involved in the **fibrotic phase** of radiation pneumonitis. - It promotes **fibroblast proliferation**, collagen synthesis, and extracellular matrix deposition, leading to lung scarring. *NF-kB* - **Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kB)** is a master **transcription factor** that regulates the expression of numerous genes involved in inflammation and immune responses. - Radiation exposure **activates NF-kB**, leading to the transcription of various pro-inflammatory cytokines, including TNF-α, which contribute to radiation pneumonitis.

Q: Most common lung cancer in non-smokers is:

Adenocarcinoma. ***Adenocarcinoma*** - **Adenocarcinoma** is the most common type of lung cancer found in non-smokers, often associated with peripheral lung nodules. - This subtype has a rising incidence rate, particularly among women and younger individuals, often linked to factors like **environmental exposures** or **genetics**. *None of the above* - This option is incorrect since adenocarcinoma is a recognized **primary lung cancer** type in non-smokers. - The statement does not address the specific cancer types and neglects to acknowledge the commonality of adenocarcinoma. *Squamous cell carcinoma* - Generally associated with smoking [1,2] and presents centrally in the lungs, making it less common among non-smokers. - Often linked to **cavitary lesions** [1] and associated with **hypercalcemia** due to parathyroid hormone-related peptide secretion. *Oat cell carcinoma* - Also known as small cell lung cancer (SCLC), is primarily linked to smoking and has a **very aggressive** nature. - Typically arises in the central airways and is associated with **paraneoplastic syndromes**, which are not relevant to the non-smoker context. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 336-337. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 720-721.

Q: Which histological type of lung cancer is most commonly associated with metastasis?

Small cell carcinoma. ***Squamous cell CA*** - Known for its **aggressive nature** and propensity to metastasize, particularly in later stages. - Typically arises in the **central part of the lungs**, often associated with smoking and leads to local invasion and distant spread. *Alveolar-carcinoma* - Rarely found and tends to be **less aggressive** compared to squamous cell carcinoma. - Usually has a more localized effect without the same potential for widespread metastasis. *Small cell carcinoma* - Although it is **highly metastatic**, it is less common than squamous cell carcinoma in terms of overall lung cancer incidence. - Characterized by its rapid growth and early metastasis [1], but mostly associated with a specific subtype of lung cancer cases. *Adenocarcinoma* - Generally presents as a **peripheral lung lesion** and has **less propensity for early metastasis** compared to squamous cell carcinoma. - More common in non-smokers and tends to have a less aggressive metastatic pattern. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 337-338.

Q: Most common type of renal carcinoma is:

Clear cell type. ***Clear cell type*** - The **clear cell type** is the most common subtype of renal carcinoma, constituting about **70-80%** of cases [3]. - It is typically associated with **von Hippel-Lindau syndrome** and presents with clear or "foamy" cells due to lipid accumulation [3]. *Chromophobe type* - This type comprises about **5-10%** of renal cell carcinomas and usually has a better prognosis [1]. - Characterized by **pale cells with distinct cell borders** and lacks the common features of clear cell carcinoma [1]. *Tubular type* - The tubular variant is less common and does not represent a major subtype of renal cell carcinoma. - It is often confused with other variants but lacks the distinct characteristics of the clear cell type. *Papillary type* - The papillary type accounts for about **10-15%** of renal carcinomas and is characterized by papillary structures [2]. - This type generally has a distinct chromosomal mutation profile compared to the clear cell type [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, p. 959. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 958-959. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 959-961.

Q: Characteristic feature of IgA nephropathy?

Serum complement level is normal. ***Serum complement level is normal*** - In **IgA nephropathy**, serum complement levels remain **normal** as this condition is not associated with complement consumption [1]. - This distinguishes it from other glomerulonephritides like **membranoproliferative GN**, where complement levels may be decreased. *Gross hematuria presents after 10 days* - Gross hematuria in IgA nephropathy often occurs **upon infection** or triggers, but not strictly after a set duration like 10 days [1]. - Typically, hematuria is seen with **episodic** flares rather than presenting consistently after a specific time frame. *More common in old age* - IgA nephropathy is actually more common in **young adults**, particularly males, rather than the elderly. - It is not characterized by age but rather often presents in **teenage years to early adulthood**. *It is a type of membranoproliferative GN* - IgA nephropathy is a **separate entity** and is predominantly characterized by the deposition of IgA in the mesangial regions [1], not classified under membranoproliferative GN. - This condition has distinct **pathological features** and immunological characteristics, differentiating it from membranoproliferative forms. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 928-929.

Q: IgA nephropathy is not associated with which of the following?

Decreased complement level. ***Decreased complement level*** - IgA nephropathy is typically associated with **normal serum complement levels** (C3 and C4), which is an important distinguishing feature. - Unlike post-streptococcal glomerulonephritis or lupus nephritis where complement levels are **low/decreased**, IgA nephropathy does not cause systemic complement consumption. - While complement activation does occur locally in the glomerulus (via lectin and alternative pathways), it does not lead to a decrease in serum complement levels. *Focal mesangial proliferation* - This is a **common histological finding** in IgA nephropathy, reflecting the proliferative response to IgA deposition in the mesangium. - The mesangial cells proliferate in an attempt to clear the immune deposits. *Gross hematuria concurrent with upper respiratory infection* - This is a **classic clinical presentation** of IgA nephropathy, often referred to as **synpharyngitic hematuria**. - The episode of gross hematuria typically occurs **within 1-2 days** of the onset of an upper respiratory tract infection, distinguishing it from post-streptococcal glomerulonephritis where hematuria appears 1-3 weeks later. *Immunofluorescence deposits contain IgA and IgG* - The defining feature of IgA nephropathy on immunofluorescence is the **predominant deposition of IgA**, often accompanied by C3. - While IgA is the primary immunoglobulin, **IgG and IgM can also be present** in variable amounts, but IgA must be the dominant or co-dominant immunoglobulin for the diagnosis.

Question 1

Which of the following does not predispose to leukemia?

Accepted Answer

Alcohol

Answer

Smoking

Answer

Chemical exposure

Answer

Genetic disorder

Question 2

Which subtype of Acute Myeloid Leukemia (AML) is associated with the best prognosis?

Accepted Answer

Acute promyeloblastic leukemia (M3)

Answer

Acute myelo monocytic leukemia.

Answer

Acute monocytic leukemia.

Answer

Erythro leukemia

Question 3

Which antigen is tested in routine Rh typing?

Accepted Answer

D antigen

Answer

C antigen

Answer

A antigen

Answer

B antigen

Question 4

Which of the following is NOT seen in polycythemia vera?

Accepted Answer

Increased erythropoietin

Answer

Intrinsic abnormality of hematopoietic precursors

Answer

Erythropoietin independent growth of red cell progenitors

Answer

Most common cause of primary polycythemia

Question 5

Radiotherapy induced radiation pneumonitis is mediated by all of the following cytokines and factors except -

Accepted Answer

PAF

Answer

NF-kB

Answer

TNF-α

Answer

TGF-β

Question 6

Most common lung cancer in non-smokers is:

Accepted Answer

Adenocarcinoma

Answer

Squamous cell carcinoma

Answer

Oat cell carcinoma

Answer

Large cell carcinoma

Question 7

Which histological type of lung cancer is most commonly associated with metastasis?

Accepted Answer

Small cell carcinoma

Answer

Squamous cell carcinoma

Answer

Adenocarcinoma

Answer

Large cell carcinoma

Question 8

Most common type of renal carcinoma is:

Accepted Answer

Clear cell type

Answer

Chromophobe type

Answer

Papillary type

Answer

Collecting duct type

Question 9

Characteristic feature of IgA nephropathy?

Accepted Answer

Serum complement level is normal

Answer

More common in old age

Answer

It is a type of membranoproliferative GN

Answer

Gross hematuria presents after 10 days

Question 10

IgA nephropathy is not associated with which of the following?

Accepted Answer

Decreased complement level

Answer

Focal mesangial proliferation

Answer

Gross hematuria concurrent with upper respiratory infection

Answer

Immunofluorescence deposits contain IgA and IgG

NEET-PG 2015

Internal Medicine

Pathology